Diclofenac Sodium Articles
World Immunology, Rheumatology Markets
28 November 1994
DDT's New Global Pharma Market Review 1994
10 October 1994
Ciba Performs Well But Hit By Currencies
5 September 1994
Injunction Against Novopharm
8 August 1994
WHAT FUTURE FOR STERLING HEALTH
4 July 1994
ITALIAN POLICE SEIZE ILLICIT DRUGS MONEY
27 June 1994
EUROPEAN PHARMA ISSUES ASSESSED BY IMS
30 May 1994
STRONG SWISS FRANCS HITS CIBA'S 1st QTR
25 April 1994
CIBA RESULTS FOR 1993 "AS PROMISED"
4 April 1994
EFFECTS OF JAPAN NHI PRICE CUTS
7 March 1994
CIBA LAUNCHES CATAFLAM NSAID IN USA
31 January 1994
MUSCULOSKELETAL MARKET TO DECLINE
6 December 1993
STRUCTURAL CHANGES AT CIBA
22 November 1993
US DRUGSTORE AUDIT DATA FOR JULY
6 September 1993
MISOPROSTOL PRAISED AT ILAR
26 July 1993
INDIA: A PATENT REGIME FOR DRUG SECURITY
21 June 1993
THREE-WAY GENERIC AGREEMENT
31 May 1993
CIBA'S 1992 HEALTH CARE PROFITS SQUEEZED
5 April 1993
1ST LAUNCH OF ARTHROTEC IN UK
8 February 1993
GLOBAL DRUG MARKET: 30 YEARS OF GROWTH
4 January 1993
US OTC ANALGESICS - A 1992 RETROSPECTIVE
4 January 1993
ANALYSTS ASSESS CIBA'S PHARMA PROSPECTS
9 November 1992
SEARLE'S ARTHROTEC APPROVED IN UK
22 June 1992
SANOFI, CIBA-GEIGY ON PARIBAS BUY LIST
13 January 1992
ANALGESICS IN THE USA -- AN OPEN DOOR FOR P&G?
6 January 1992
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
